• LAST PRICE
    0.2719
  • TODAY'S CHANGE (%)
    Trending Up0.0044 (1.6449%)
  • Bid / Lots
    0.2708/ 10
  • Ask / Lots
    0.2725/ 1
  • Open / Previous Close
    0.2675 / 0.2675
  • Day Range
    Low 0.2607
    High 0.2793
  • 52 Week Range
    Low 0.1830
    High 8.1700
  • Volume
    1,521,119
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.2675
TimeVolumeSYRS
09:32 ET597710.2667
09:33 ET122160.2675
09:35 ET98410.270349
09:37 ET115980.2731
09:39 ET292540.2656
09:42 ET926870.2741
09:44 ET222210.2721
09:46 ET313350.272
09:48 ET237380.2751
09:50 ET70470.2727
09:51 ET226260.270249
09:53 ET154310.267801
09:55 ET425790.26995
09:57 ET68320.27095
10:00 ET65760.27359
10:02 ET33750.2692
10:04 ET56140.271
10:06 ET596320.2743
10:08 ET28450.2704
10:09 ET179210.26831
10:11 ET98890.27
10:13 ET353430.27
10:15 ET145270.2709
10:18 ET240980.2736
10:20 ET1719390.2607
10:22 ET344870.2692
10:24 ET72950.2681
10:26 ET212820.2658
10:27 ET25890.2669
10:29 ET53440.2637
10:33 ET48880.2668
10:36 ET191490.269
10:38 ET351530.270857
10:40 ET161050.2725
10:42 ET83080.2682
10:44 ET37150.272999
10:45 ET71540.2682
10:47 ET77660.2688
10:49 ET267950.2712
10:51 ET70700.2699
10:54 ET47840.2708
10:56 ET225140.267
10:58 ET20400.265301
11:00 ET2600.2703
11:02 ET12460.2656
11:03 ET54690.2693
11:05 ET165800.2675
11:07 ET460410.2653
11:09 ET508290.27
11:12 ET3710.2655
11:14 ET151460.2704
11:16 ET362100.2693
11:18 ET305970.267501
11:20 ET26350.2699
11:21 ET48250.2711
11:23 ET35860.269001
11:25 ET68470.2703
11:27 ET66090.2729
11:30 ET2730.2725
11:32 ET35850.2733
11:34 ET111900.271
11:36 ET80280.2732
11:38 ET280260.273
11:39 ET40960.2748
11:41 ET12170.2748
11:43 ET116950.276
11:45 ET97830.2769
11:48 ET501480.271
11:52 ET370200.2739
11:54 ET77830.26931
11:56 ET67120.2738
11:57 ET36410.2744
11:59 ET31340.27
12:01 ET73000.2745
12:03 ET1000.2746
12:06 ET83840.2746
12:08 ET147550.277868
12:10 ET66310.2741
12:12 ET1000.2741
12:14 ET40540.2741
12:15 ET60560.2714
12:17 ET32000.2733
12:19 ET46230.2741
12:21 ET27300.2725
12:24 ET60750.2719
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSYRS
Syros Pharmaceuticals Inc
6.7M
-0.1x
---
United StatesBGLC
BioNexus Gene Lab Corp
4.3M
-6.1x
---
United StatesJAGX
Jaguar Health Inc
11.7M
-0.1x
---
United StatesLSB
LakeShore Biopharma Co Ltd
56.9M
-0.5x
---
United StatesMCUJF
Medicure Inc
7.4M
-3.9x
---
United StatesROSGQ
Rosetta Genomics Ltd
590.0
0.0x
---
As of 2024-11-29

Company Information

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies. The Company is advancing Tamibarotene, a selective retinoic acid receptor alpha (RARα), agonist for which the Company is conducting SELECT-MDS-1, a Phase III clinical trial evaluating tamibarotene in combination with azacitidine in a genomically defined subset of patients with higher-risk myelodysplastic syndrome (HR-MDS), and for which it is conducting SELECT-AML-1, a randomized Phase II clinical trial evaluating tamibarotene in combination with venetoclax and azacitidine in a genomically defined subset of newly diagnosed patients with acute myeloid leukemia (AML). Its other assets include SY-2101 and SY-5609. The Company is seeking out-licensing opportunities for the further development of SY-5609, its highly selective and potent inhibitor of cyclin dependent kinase 7 (CDK7).

Contact Information

Headquarters
35 Cambridge Park DriveCAMBRIDGE, MA, United States 02140
Phone
617-744-1340
Fax
617-744-1377

Executives

Independent Chairman of the Board
Peter Wirth
President, Chief Executive Officer, Director
Gerald Quirk
Chief Development Officer
Kristin Stephens
Director
Nancy Simonian
Independent Director
Marsha Fanucci

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.7M
Revenue (TTM)
$386.0K
Shares Outstanding
26.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.37
EPS
$-3.03
Book Value
$0.63
P/E Ratio
-0.1x
Price/Sales (TTM)
17.4
Price/Cash Flow (TTM)
---
Operating Margin
-28,927.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.